LGLalit Kumar Gupta

Lalit Kumar Gupta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lalit Kumar Gupta has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Asit Mittal

    Department of Dermatology, Rabindranath Tagore Medical College, Udaipur, Rajasthan, India

    24 shared publications
  • Manisha Balai

    Department of Dermatology, RNT Medical College, Udaipur, Rajasthan, India

    21 shared publications
  • Sharad Mehta

    Department of Dermatology, Venereology and Leprosy, R.N.T. Medical College, Udaipur, Rajasthan, India

    15 shared publications
  • Ashok Kumar Khare

    Department of Dermatology, Venereology and Leprosy, R.N.T. Medical College, Udaipur, Rajasthan, India

    12 shared publications
  • AshokKumar Khare

    Department of Dermatology, Venereology and Leprosy, RNT Medical College, Udaipur, Rajasthan, India

    6 shared publications
  • Ankita Srivastava

    5 shared publications

Latest Publications

  • Open Access

    Clinico-epidemiological Spectrum of Childhood Vitiligo at a Tertiary Care Center of South Rajasthan

    by Kiran Poswal, Manisha Balai, Lalit Kumar Gupta, Ram Niwas Vishnoi

    Background: Vitiligo is an acquired, multifactorial disorder of depigmentation and has serious psychological impact. Childhood vitiligo has different characteristics as compared to adult-onset vitiligo. Aims and Objective: To evaluate the burden and clinical characteristics of childhood vitiligo (age ≤18 years) attending skin outpatient department (OPD) and association with other autoimmune diseases. Materials and Methods: A cross-sectional hospital-based study of 152 childhood vitiligo cases (aged ≤18 years) attending dermatology OPD of a tertiary health care center of South Rajasthan for 1 year. After obtaining informed consent and a detailed history, cutaneous, general and systemic examination was performed and relevant investigations were carried out. Data analysis was done using the SPSS software version 16.0 and Microsoft Excel. Result: Of the total 152 patients, females outnumbered males and the M:F ratio was 1:1.53. The mean age at the presentation was 11.82 years and the mean age of onset of vitiligo was 9.78 ± 3.60 years with the mean duration of disease was 1.96 ± 1.99 years. The most common type was generalized vitiligo (67.8%) followed by segmental vitiligo (17.1%). The most common site of onset of vitiligo was eyelid. Positive family history was seen in 17 (11.18%) patients. Leukotrichia was seen in 21% of patients. Majority of patients had Vitiligo Area Scoring Index (VASI) <10 and children with the positive family history of vitiligo had higher mean VASI than those with a negative family history of vitiligo, which was statistically not significant. Conclusion: A female preponderance with prominent involvement of eyelids as the initial and most common site of affection was seen in our study.

  • Open Access

    A Demographic and Biochemical Profile of Patients with Premature Graying of Hair (Canities) at a Tertiary Care Centre: A Case–Control Study

    by Laxman Kumar, Lalit K. Gupta, Manisha Balai, Asit Mittal, Ritu Maida

    Background: Premature graying of hair (PGH) is a significant concern for individuals, as it is frequently perceived as an indicator of advancing age and reduced vitality, and can lead to lower self-esteem and psychological distress. Deficiencies of vitamin B12, vitamin D3 and ferritin may be related to PGH. Nevertheless, data on the specific risk factors and biochemical parameters for PGH in India are relatively limited. Aim and Objective: This study was conducted to examine the various demographic and potential risk factors, along with biochemical variables linked to PGH. Patients and Methods: An analytical case–control study was conducted on patients attending the skin outpatient department with PGH. The control group comprised age- and gender-matched patients and attendants with other dermatoses. Various demographic factors and potential risk factors were documented and compared with control groups. Measurement of serum ferritin, calcium, hemoglobin, vitamin D3, vitamin B12, lipid profile, and thyroid profile was done and analyzed between the cases and controls. Results: Males outnumbered females with a male-to-female ratio of 1.5:1. Most of the cases of PGH belonged to the age group of 15–25 years (71.5%). On binary multivariate regression analysis, statistically significant differences in family history, smoking and hair plucking compared to controls were noted. Additionally, the cases had considerably lower levels of serum ferritin ( P = 0.020), vitamin B12 ( P = 0.012), and vitamin D3 ( P = 0.043). Limitations: This study was done at a single center. We plan to conduct a multicentric study in the future. Recall bias may also be a limitation in the study. The patients were not followed-up after correction to assess it’s effect. Conclusion: Identifying modifiable risk factors and correcting biochemical abnormalities may help in preventing and better managing patients with PGH.

  • Open Access

    Generalized Lichen Nitidus Successfully Treated with Cyclosporine

    by Laxman Kumar, Lalit Kumar Gupta, Manisha Balai, Nirmal Chouhan

  • Open Access

    PRACT-India: Practical Recommendations on Acne Care and Medical Treatment in India—A Modified Delphi Consensus

    by Nina Madnani, Abir Saraswat, Anand Nott, Deepak Jakhar, Lalit Kumar Gupta, Malavika Kohli, Manas Ranjan Puhan, Prabhakar Sangolli, Rahul Nagar, Sanjay Kumar Rathi, et al.

    Background/Objectives: Acne vulgaris is a prevalent dermatological condition, yet clear, region-specific management guidelines, particularly for India’s diverse population, remain limited. Effective acne management extends beyond pharmacologic therapy, emphasizing proper skincare, patient education, and adherence strategies. This consensus aims to provide tailored, evidence-based recommendations for optimizing acne treatment in the Indian context. Methods: A panel of 14 dermatology experts with ≥15 years of experience reviewed literature, real-world clinical practices, and patient-centric factors relevant to acne management in India. Using a modified Delphi process with two virtual voting rounds, 61 statements across seven clinical domains were evaluated. Consensus was defined as ≥75% agreement. Results: Topical retinoids remain the first-line therapy, with combination regimens (benzoyl peroxide or topical antibiotics) preferred to enhance efficacy and minimize antibiotic resistance. Hormonal therapies, including combined oral contraceptives and spironolactone, are recommended for females with resistant acne. Guidance includes individualized treatment plans, baseline investigations, and selection of appropriate topical and systemic agents. Special considerations for pregnancy and lactation prioritize maternal and fetal safety. Conclusions: This expert consensus provides practical, evidence-based recommendations for acne management in India, integrating pharmacological and non-pharmacological approaches. The tailored guidance supports individualized care, antibiotic stewardship, and improved treatment adherence, aiming to enhance patient outcomes nationwide.


  • Open Access

    Angiolymphoid Hyperplasia with Eosinophilia

    by Rini Makhija, Laxman Kumar, Manisha Balai, Lalit K. Gupta

  • Open Access

    Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent

    by Ankur Kumar Jindal, Archan Sil, Ridhima Aggarwal, Keshavamurthy Vinay, Anuradha Bishnoi, Deepti Suri, Amit Rawat, Muthu Sendhil Kumaran, Biman Saikia, Rashmi Sarkar, et al.

    Hereditary angioedema (HAE) is an uncommon disorder characterized clinically by recurrent episodes of nonitchy subcutaneous and/or submucosal swellings. The estimated prevalence of HAE is ~ 1: 10,000 to 1: 50,000. There are no prevalence data from India, however, estimates suggest that there are 27,000 to 135,000 patients with HAE in India at present. The majority of these, however, remain undiagnosed. Replacement of plasma-derived or recombinant C1-esterase inhibitor (C1-INH) protein, administered intravenously, is the treatment of choice during the management of acute episodes of angioedema (i.e., “on-demand treatment”) and is also useful for short-term prophylaxis (STP) and long-term prophylaxis (LTP). This has been found to be effective and safe even in young children and during pregnancy. Until recently, none of the first-line treatment options were available for “on-demand treatment,” STP or LTP in India. As a result, physicians had to use fresh frozen plasma for both “on-demand treatment” and STP. For LTP, attenuated androgens (danazol or stanozolol) and/or tranexamic acid were commonly used. These drugs have been reported to be useful for LTP but are associated with a significant risk of adverse effects. Intravenous pd-C1-INH, the first-line treatment option, is now available in India. However, because there is no universal health insurance, access to pd-C1-INH is a significant challenge. HAE Society of India has developed these consensus guidelines for India and other resource-constrained settings where plasma-derived C1-INH therapy is the only available first-line treatment option for the management of HAE and diagnostic facilities are limited. These guidelines have been developed because it may not be possible for all patients to access the recommended therapy and at the recommended doses as suggested by the international guidelines. Moreover, it may not be feasible to follow the evaluation algorithm suggested by the international guidelines.


  • Open Access

    Trigeminal trophic syndrome

    by LalitK Gupta, Manju Meena, AshokK Khare


  • Open Access

    Linear fixed drug eruptions to Levofloxacin

    by Lalit K. Gupta

    Published on behalf of INDIAN ASSOCIATION OF DERMATOLOGISTS, VENEREOLOGISTS AND LEPROLOGISTS, WEST BENGAL STATE BRANCH.